BMS Announces Operational Restructuring with Q3 Financials

Oct 27, 2016

In addition to announcing positive third quarter results this week, Bristol-Myers Squibb Company also revealed plans for a restructuring of the company’s operating model.

The restructuring is designed to help BMS focus resources behind the its highest priorities, accelerate its pipeline and simplify infrastructure.

Specifically, according to BMS, the new model will involve a "more focused investment in commercial opportunities against key brands and markets, a competitive and more agile R&D organization that can accelerate the pipeline, streamlined operations and realigned manufacturing capabilities that broaden biologics capabilities to reflect current and future portfolio."

Read the BMS press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments